Amarin Corp Plc (AMRN)

[ranjo]

no matter how robust the numbers are there will be hit pieces written by some highly respected cardiologist who will cast doubt on the results; the inert placebo or the credibility of some location that had more favorable results -its all part of the game we play. They can magnify a sub part that seemingly shows no statistical significance comparing vascepa to otc fish oil, etc. If reduce it is moderately successful say anything close to 20% they won't find a safer add on to statin which is our game changer. Matter of fact it may mitigate the muscle soreness or any other adverse effect enabling those who can't tolerate statins to now be able to benefit from a vascepa combo. I've been long since early 10' and added a while back so I expect a higher RRR than I mentioned.